Electrophysiological effects of risperidone in mammalian cardiac cells
暂无分享,去创建一个
Pál Pacher | László Fülöp | T. Bányász | N. Szentandrassy | J. Magyar | P. Nanasi | P. Pacher | Z. Bagi | János Magyar | Tamás Bányász | Zsolt Bagi | Norbert Szentandrássy | Valéria Kecskeméti | Péter Nánási | V. Kecskeméti | László Fülöp | N. Szentandrássy
[1] Dierk Thomas,et al. The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. , 2002, The Journal of pharmacology and experimental therapeutics.
[2] D. Rampe,et al. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG. , 1998, The Journal of pharmacology and experimental therapeutics.
[3] M. Tohen,et al. Risperidone in the elderly: a pharmacoepidemiologic study. , 1997, Journal of Clinical Psychiatry.
[4] J. Czekalla,et al. Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis. , 2001, The Journal of clinical psychiatry.
[5] László Virág,et al. The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization , 2000, The Journal of physiology.
[6] D. Gardner,et al. A case of risperidone overdose in early schizophrenia: a review of potential complications. , 1998, Journal of psychiatry & neuroscience : JPN.
[7] J. Tamargo,et al. Imipramine blocks rapidly activating and delays slowly activating K+ current activation in guinea pig ventricular myocytes. , 1994, Circulation research.
[8] C. January,et al. Droperidol Lengthens Cardiac Repolarization due to Block of the Rapid Component of the Delayed Rectifier Potassium Current , 1999, Journal of cardiovascular electrophysiology.
[9] A H Glassman,et al. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. , 2001, The American journal of psychiatry.
[10] C. Wurthmann,et al. Randomized, Double‐Blind, Controlled Trial of Risperidone Versus Clozapine in Patients With Chronic Schizophrenia , 1995, Journal of clinical psychopharmacology.
[11] M. Kamalesh,et al. Effect of risperidone on QT interval and QT dispersion in the elderly. , 2000, Heart disease.
[12] S. Ayis,et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients , 2000, The Lancet.
[13] D. Flockhart,et al. Prolongation of QT interval in isolated feline hearts by antipsychotic drugs. , 1998, Journal of clinical psychopharmacology.
[14] Psychotropic drugs and long QT syndromes: case reports. , 1985, The Journal of clinical psychiatry.
[15] R. Friedman,et al. Prolongation of the Corrected QT and Torsades de Pointes Cardiac Arrhythmia Associated with Intravenous Haloperidol in the Medically III , 1993, Journal of clinical psychopharmacology.
[16] A. Peer,et al. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects , 1993, Clinical pharmacology and therapeutics.
[17] S. Finkel. Managing the behavioral and psychological signs and symptoms of dementia , 1997, International clinical psychopharmacology.
[18] S. Hohnloser,et al. Proarrhythmia with Class III Antiarrhythmic Drugs: Definition, Electrophysiologic Mechanisms, Incidence, Predisposing Factors, and Clinical Implications , 1995, Journal of cardiovascular electrophysiology.
[19] Bertram Pitt,et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.
[20] A. Jednákovits,et al. Electrophysiological effects of bimoclomol in canine ventricular myocytes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[21] B. Sakmann,et al. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.
[22] C. McDougle,et al. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. , 1998, Archives of general psychiatry.
[23] Sheng-Nan Wu,et al. Characterization of Inhibition by Risperidone of the Inwardly Rectifying K+ Current in Pituitary GH3 Cells , 2000, Neuropsychopharmacology.
[24] B Attali,et al. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes , 1997, British journal of pharmacology.
[25] R Lazzara,et al. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. , 1996, Circulation.
[26] Z. Ungvari,et al. Electrophysiological effects of fluoxetine in mammalian cardiac tissues , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.
[27] J. Levenson,et al. Fatal Cardiac Event following Initiation of Risperidone Therapy , 1997, The Annals of pharmacotherapy.
[28] C. Funck-Brentano,et al. Influence of dofetilide on QT-interval duration and dispersion at various heart rates during exercise in humans. , 1996, Circulation.
[29] L. Ereshefsky,et al. Pharmacological profile of risperidone. , 1993, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[30] A. Avenoso,et al. Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone , 1999, Psychopharmacology.
[31] B. Drolet,et al. Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current. , 1999, The Journal of pharmacology and experimental therapeutics.
[32] Z. Ungvari,et al. Electrophysiological changes in rat ventricular and atrial myocardium at different stages of experimental diabetes. , 1999, Acta physiologica Scandinavica.
[33] D. Snyders,et al. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. , 1990, Circulation.
[34] A. S. Davis. The pre-clinical assessment of QT interval prolongation: a comparison of in vitro and in vivo methods , 1998, Human & experimental toxicology.
[35] T. Barnes,et al. Electrocardiographic changes in patients receiving neuroleptic medication , 1996, Acta psychiatrica Scandinavica.